Past Webinars

NOTE: Due to the large file size of some webinars we are having technical difficulties with uploading them to our website. We’re working on fixing the issue, but in the meantime if you would like us to send you one of the webinars below, please contact us at skeiser@bcaction.org. Thank you!

New Report on Breast Cancer and the Environment: A Briefing for Advocates (Jan 2012)

Breast Cancer Action’s executive director, Karuna Jaggar presented joined by Janet Ackerman, Research Assistant at the Silent Spring Institute on Jan 24th and joined by Ruthann Rudel, MS, Director of Research at the Silent Spring Institute on Jan 25th.

The webinar provided:

• BCAction’s commentary and analysis of the IOM report on breast cancer and the environment
• A summary of where the report got it right and where it missed the mark
• A focus on the limits of individual behavior and the policy changes required to reduce these exposures to toxins that may be contributing to the skyrocketing rates of breast and other cancers
• Review the committee’s recommendations and discuss how advocates can move these recommendations forward

 

Toxic Cosmetics: What’s in Your Personal Care Products and What You Can Do About It (November 2011)

Co-hosted by Nneka Leiba, Senior Analyst with the Environmental Working Group and Mia Davis, Organizing Director with the Campaign for Safe Cosmetics. Through this webinar you’ll learn:

• A brief summary of the problem with cosmetic regulation
• Who is at risk when it comes to toxins in personal care products
• Why we need safer cosmetics
• What chemicals we’re talking about when we say “toxic cosmetics”
• Current and past legislation aimed at regulating cosmetics
• Ways for you to take action to protect everyone’s health There will be time for questions, so bring your questions!

 

Make Action Speak Louder Than Pink (October 2011)

Co-hosted by author of Pink Ribbon Blues Gayle Sulik. This webinar covers:

• Why the pink ribbon appears on so many products, especially in October
• The history of Breast Cancer Awareness Month and its corporate ties
• How BCAction’s Think Before You Pink campaign has challenged pinkwashers for 10 years
• Ways you can take action in BCAction’s Raise a Stink! campaign

 

Gene Patenting (August 2011)

This webinar addresses gene patenting and its implications for women around the world. Participants learn about the latest news in the Myriad Genetics case, along with the basic science, patent law, and current campaign efforts. Breast Cancer Action is a plaintiff in the lawsuit to invalidate Myriad Genetics’ patents on the breast cancer genes BRCA 1 and 2 because patients should always come before profits.

Sorting Out the Confusion: An In-Depth Look at Breast Cancer Screening (July 2011)

When the U.S. Preventive Services Task Force (USPSTF) announced new recommendations for mammography screening in 2009, the ensuing media frenzy generated a lot of heated conversation. In the midst of that debate, BCAction was one of the few breast cancer organizations to acknowledge mammography’s limitations and call for safer, more effective screening methods. This webinar delineates the risks and benefits of breast cancer screening, review the science behind the USPSTF’s recommendations, and provide attendees with tools for understanding media coverage of mammography. Join us for an illuminating look at a complex and often confusing issue.

Featuring: Tracy Weitz, BCAction Board Chair and Director, Advancing New Standards in Reproductive Health (ANSIRH), University of California, San Francisco

Big Pharma, the FDA and Breast Cancer: Patients Before Profit (June 2011)

Following The Politics of Breast Cancer webinar in May, we turned BCAction’s critical eye on the FDA and its drug approval process.

Breast cancer treatments should be both the most effective and the least toxic possible. The standards used by the FDA for the approval of new breast cancer therapies and devices should ensure this outcome. However, pharmaceutical companies, the government and cancer patients don’t share the same interests.  This webinar will talk about whom the power players at the FDA are, BCAction’s take on the related conflicts of interests, and the history of the approval process.

 

The Politics of Breast Cancer (May 2011)

Why does BCAction so fiercely object to Breast Cancer Awareness Month? What is so wrong with pink ribbon marketing? Why on earth would corporations involved in the treatment and diagnosis of women with breast cancer try to control how the public understands the disease?

Here’s a crash course on the “pinking” of breast cancer, environmental causes of the disease and the corporate interests that control what the public hears about the epidemic.